| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.94B | 12.61B | 11.42B | 16.25B | 18.71B | 16.62B |
| Gross Profit | 1.60B | 1.63B | 1.37B | 1.58B | 2.19B | 1.96B |
| EBITDA | 2.08B | 2.26B | 402.00M | 651.98M | 1.32B | 1.06B |
| Net Income | 1.44B | 1.58B | 548.26M | 569.98M | 974.20M | 790.52M |
Balance Sheet | ||||||
| Total Assets | 15.98B | 15.86B | 17.14B | 15.61B | 16.87B | 16.15B |
| Cash, Cash Equivalents and Short-Term Investments | 7.00B | 7.59B | 6.16B | 5.77B | 4.03B | 4.37B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.09B | 2.26B | 2.60B | 2.11B | 2.62B | 2.90B |
| Stockholders Equity | 13.89B | 13.59B | 14.54B | 13.51B | 14.24B | 13.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 500.71M | 551.90M | 2.52B | 94.59M | 332.71M |
| Operating Cash Flow | 0.00 | 579.79M | 684.68M | 2.54B | 180.01M | 363.91M |
| Investing Cash Flow | 0.00 | 1.52B | 166.77M | 19.76M | -93.61M | -40.68M |
| Financing Cash Flow | 0.00 | -676.56M | -457.99M | -824.05M | -425.58M | -447.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥23.89B | 8.17 | ― | 3.21% | 9.61% | 173.72% | |
77 Outperform | ¥21.07B | 15.72 | ― | 3.63% | 18.02% | 18.04% | |
75 Outperform | ¥25.82B | 13.56 | ― | 2.47% | 3.53% | 8.36% | |
66 Neutral | ¥27.15B | 11.96 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥19.07B | 10.08 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥15.80B | 12.90 | ― | 2.78% | 1.30% | -5.03% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Japan Pure Chemical Co., Ltd. has announced an update on its gain from the sale of investment securities, which aligns with its medium-term management plan to reduce the ratio of net assets. The company expects to complete the sale by the third quarter, with the gain on sale now estimated to increase due to rising stock prices, impacting the fiscal year ending March 31, 2026.
Japan Pure Chemical Co., Ltd. has revised its full-year earnings forecast for the fiscal year ending March 31, 2026, maintaining its net sales and profit projections while significantly increasing its net profit forecast due to extraordinary income from the sale of investment securities. This strategic move aligns with the company’s medium-term management plan to reduce the ratio of net assets, potentially impacting stakeholders by enhancing financial stability and shareholder returns.
Japan Pure Chemical Co., Ltd.’s interim financial report highlights the variability in sales between noble metals combined with chemicals and standalone chemical sales. The fluctuating prices of noble metals significantly influence overall sales, impacting the company’s financial performance and market positioning.
Japan Pure Chemical Co., Ltd. reported a 19% increase in net sales for the six months ending September 30, 2025, compared to the same period last year. However, the company’s net profit decreased by 24%, reflecting challenges in maintaining profitability despite increased sales. The company has maintained its dividend forecast, indicating stability in shareholder returns, and plans to submit its semiannual report by November 10, 2025. The financial results suggest a mixed performance, with growth in sales but a decline in net profit, which could impact investor sentiment and strategic planning.